Journal · Updated 2026-08-11
Generic Liraglutide: The Class's First Real Generic, and When It's Worth a Quote
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
The class's patent wall cracked first at its oldest member: generic liraglutide entered the US market in 2024, creating the only true generic lane any GLP-1 offers — daily injections with SCALE-era expectations (~8% average loss at the 3.0 weight dose; diabetes-dose products generic'd most cleanly), at prices that vary enormously by pharmacy, dose, and discount card rather than sitting at one quotable number. The honest positioning: nobody's first choice on results (weekly semaglutide and tirzepatide roughly double the studied loss), and a legitimately useful quote to collect for two buyers — the coverage-blocked cash payer whose local generic price genuinely undercuts the $99–$149 semaglutide floor tier, and the formulary patient whose plan covers generic liraglutide at a tier the branded drugs can't reach. The rule: it competes on a real number from your pharmacy counter, never on the word "generic" alone.
Getting and judging the quote
Mechanics first: ask your pharmacy (and a discount-card check) for generic liraglutide pricing at the dose your prescriber would actually use — quotes swing by hundreds of dollars across channels and quantities, which is why this page refuses to print one — then judge it against the board: the semaglutide floor ($99–$139 compounded, $149 approved oral), your coverage situation, and the adherence reality of daily injections (weekly agents win persistence data decisively; a cheaper drug you quit is the expensive one). Where the old molecule holds real cards: it's an approved, manufactured, pharmacy-dispensed product — no compounding-lane questions, no verification homework, no BUD math — which for some buyers is worth more than the efficacy gap costs; its decade-deep safety archive is the class's longest; and its faster daily clearance occasionally suits clinical edge cases (the Saxenda comparison covers the rest). Where it doesn't: any buyer chasing maximum results, for whom the 8%-versus-15-to-21% gap ends the conversation before price begins. Collect the quote; run the board; let arithmetic — not nostalgia or novelty — pick the molecule.
Questions people ask
Is there a generic Ozempic or Wegovy?
No — semaglutide and tirzepatide remain patent-protected with no generics. The class's only true generic is liraglutide (daily injection, ~8% SCALE-era results), available since 2024 at prices that vary widely by pharmacy and dose.
How much does generic liraglutide cost?
Genuinely variable — by pharmacy, dose, quantity, and discount card — which is why the move is collecting your own quote rather than trusting a printed number. Judge it against the $99–$149 semaglutide floor tier and your coverage; it sometimes wins and often doesn't.
Is generic liraglutide better than compounded semaglutide?
Different trade: liraglutide is an approved, manufactured product (no verification homework) with weaker results (~8% vs ~15%) and daily injections; compounded semaglutide offers the stronger molecule unapproved, at $99–$139, with the full verification checklist. Budget, adherence style, and risk tolerance decide.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.